There are many conflicting guidelines when it comes to screening for cancer. Some say screenings should be widely used as early as possible. Others contend it actually does more harm than good to over-screen and potentially overdiagnose and overtreat slow-moving, non-aggressive cancers.
The independent panel of national evidence-based medicine experts, known as the US Preventive Forces Task Force, weighs in on a regular basis with their recommendations for cancer screening guidelines after an exhaustive review of the available evidence. Still, their recommendations are not always an easy sell to people because the idea of real harm coming from a simple screening test is hard to digest. On today's show, we’ll provide plenty of thoughts for you to chew on regarding cancer screenings, and the idea of overdiagnosis and overtreatment. How can a consumer make sense of it all?
Dr. Stan Gerson, Director of the Case Comprehensive Cancer Center
Dr. Joanna Brell, Associate Cancer Center Director for Clinical Research at MetroHealth
Dr. Henry Blair, Co-Director of the Hirsch Cancer Center at Cleveland Clinic's Hillcrest Hospitaland member of the Cleveland American Cancer Society Leadership Council
Making Sense of Cancer Screening Guidelines
